Prognostic Factors in Tuberculosis Related Mortalities in Hospitalized Patients

Table 4

Patient profile: smokers versus nonsmokers*.

Feature	Smoker	Nonsmoker	P	OR (95% CI)
Patients, 𝑁 (%)	43/120 (35.8)	77/120 (64.1)	<0.01	n/a
Cases, 𝑁 (%)	32/43 (74.4)	28/77 (36.4)	<0.01	2.04 (1.45–2.88)
Controls, 𝑁 (%)	11/43 (25.6)	49/77 (63.6)	<0.01	0.40 (0.23–0.68)
Age, mean years	48.49	35.23	<0.01	n/a
Weight, mean kg	41.74	43.43	0.46	n/a
Male sex, 𝑁 (%)	34/43 (79.1)	34/77 (50)	<0.01	0.20 (0.08–0.49)
Bilateral lung involvement, 𝑁 (%)	18/43 (41.9)	20/77 (26)	0.07	0.48 (0.22–1.07)
Pulmonary fibrosis, 𝑁 (%)	12/43 (27.9)	15/77 (19.5)	0.28	1.60 (0.66–3.83)
Type II respiratory failure, 𝑁 (%)	10/43 (23.3)	9/77 (11.7)	0.09	2.29 (0.84–6.17)
Duration of hospital stay, mean days	8.8	13.4	0.02	n/a
TLC ×10^9/L, mean	11.7	9.9	0.12	n/a
Neutrophils, mean %	84.0	78.1	0.02	n/a
Serum protein U/L, mean	5.09	6.11	<0.01	n/a

∗OR: odds ratio; CI: confidence interval; TLC: total leukocyte count; n/a: not applicable.